top of page
Browse by category
Search
3D imaging and AI provides more accurate assessments of body fat and muscle distribution
A recent study that used an innovative method for analysing body composition using advanced 3D imaging and deep learning techniques, has...
Fractyl Health provides update on clinical studies priorities
Fractyl Health is prioritising its REMAIN-1 pivotal study, addressing the demand for an off-ramp to GLP-1 drugs, while advancing its...
D&D Pharmatech completes enrolment in trial evaluating DD01 Dual GLP-1/Glucagon receptor agonist for MASH
D&D Pharmatech has completed patient enrolment in DD01-DN-2, an ongoing Phase 2 trial designed to evaluate the efficacy and safety of...
Helix launches world's largest clinico-genomic cohort of GLP-1 agonist treated
Helix has launched a new comprehensive clinico-genomic dataset of over 15,000 patients treated with glucagon-like-peptide-1 (GLP-1)...
Micronutrient deficiencies are common in people with type 2 diabetes
Micronutrient deficiencies are common in people with type 2 diabetes, according to the findings of a pooled data analysis of the...
TNF Pharmaceuticals initiates study evaluating TNF-alpha inhibitor isomyosamine in preserving lean muscle mass after GLP-1
TNF Pharmaceuticals has initiated the first in a series of studies to evaluate the impact of its novel oral TNF-alpha (TNF-α) inhibitor...
Browse by tag
bottom of page